Targeted Oncology9d
VLS-1488 Gains FDA Fast Track Status in Advanced Ovarian Cancer
The FDA has granted VLS-1488 fast track designation in patients with platinum-resistant high-grade serous ovarian cancer.
Frontiers10d
An unusual pattern of endometrial involvement: superficial spreading squamous cell carcinoma of the cervix
Cervical SCC, spreading superficially to the inner surface of the uterus and replacing the endometrium with carcinoma cells, is called superficial spreading SCC (2). It is not included in the 2020 ...
ascopubs.org17d
Racial discrepancies in initial presentation and diagnosis of patients with endometrial cancer.
Association between Medicaid expansion and stage at diagnosis and treatment rates of non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This ...
Daily23d
Merck gets positive EU CHMP opinions for Keytruda regimens for patients with two types of Gynecologic cancers
The first opinion recommends the approval of KEYTRUDA in combination with carboplatin and paclitaxel, followed by KEYTRUDA as a single agent, for the first-line treatment of adult patients with ...
Pharmabiz24d
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers
The first opinion recommends the approval of Keytruda in combination with carboplatin and paclitaxel, followed by Keytruda as a single agent, for the first-line treatment of adult patients with ...